RegentAtlantic Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $234K | Sell |
4,690
-144
| -3% | -$7.19K | 0.01% | 607 |
|
|
2022
Q2 | $269K | Buy |
4,834
+64
| +1% | +$3.56K | 0.01% | 569 |
|
|
2022
Q1 | $265K | Buy |
4,770
+280
| +6% | +$15.6K | 0.01% | 598 |
|
|
2021
Q4 | $251K | Buy |
4,490
+318
| +8% | +$17.8K | 0.01% | 612 |
|
|
2021
Q3 | $200K | Buy |
+4,172
| New | +$200K | 0.01% | 639 |
|
|
2015
Q1 | – | Sell |
-2,770
| Closed | -$58.6K | – | 730 |
|
|
2014
Q4 | $58.6K | Buy |
+2,770
| New | +$58.6K | 0.01% | 555 |
|